SMURF1 leads to the β-catenin signaling-mediated progression of esophageal squamous carcinoma by losing PATZ1-induced CCNG2 transcription

[Display omitted] Cyclin G2 (CCNG2), a known inhibitor of cell cycle progression, has been identified as a suppressor for the canonical β-catenin pathway. This study explores the impact of CCNG2 on β-catenin activity and malignant characteristics of esophageal squamous cell carcinoma (ESCC) cells, a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biochemical pharmacology 2025-02, Vol.232, p.116688, Article 116688
Hauptverfasser:	Chen, Lingling, Tang, Jie, Chang, Yunli, Hang, Dongyun, Ji, Jieru, Chen, Guoyu
Format:	Artikel
Sprache:	eng
Schlagworte:	CCNG2 ESCC progression PATZ1 SMURF1 β-catenin signaling
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!